Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards.
Oseltamivir (Tamiflu®) is the most widely used drug against influenza infections and is extensively stockpiled worldwide as part of pandemic preparedness plans. However, resistance is a growing problem and in 2008-2009, seasonal human influenza A/H1N1 virus strains in most parts of the world carried...
Guardado en:
Autores principales: | Josef D Järhult, Shaman Muradrasoli, John Wahlgren, Hanna Söderström, Goran Orozovic, Gunnar Gunnarsson, Caroline Bröjer, Neus Latorre-Margalef, Jerker Fick, Roman Grabic, Johan Lennerstrand, Jonas Waldenström, Ake Lundkvist, Björn Olsen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb449c3e127349b8b9eb8188b851bc0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds.
por: Goran Orozovic, et al.
Publicado: (2011) -
Flexibility of continental navigation and migration in European mallards.
por: Mariëlle L van Toor, et al.
Publicado: (2013) -
Shedding light on avian influenza H4N6 infection in mallards: modes of transmission and implications for surveillance.
por: Kaci K VanDalen, et al.
Publicado: (2010) -
Intra- and inter-pandemic variations of antiviral, antibiotics and decongestants in wastewater treatment plants and receiving rivers.
por: Andrew C Singer, et al.
Publicado: (2014) -
Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus
por: Li Y, et al.
Publicado: (2017)